BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25418900)

  • 61. The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth.
    Lobo J; Ohashi R; Helmchen BM; Rupp NJ; Rüschoff JH; Moch H
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New entities, new technologies, new findings: A review of the cytologic features of recently established subtypes of renal cell carcinoma.
    Robila V; Kraft AO; Smith SC
    Cancer Cytopathol; 2019 Feb; 127(2):79-97. PubMed ID: 30690877
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance.
    Tretiakova M; Kwon JW; Paner GP
    Adv Anat Pathol; 2024 May; 31(3):157-168. PubMed ID: 38525552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.
    Cimadamore A; Cheng L; Scarpelli M; Massari F; Mollica V; Santoni M; Lopez-Beltran A; Montironi R; Moch H
    Transl Androl Urol; 2021 Mar; 10(3):1506-1520. PubMed ID: 33850785
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gleason and Fuhrman no longer make the grade.
    Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
    Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Histopathological spectrum of adult renal tumours: A single center experience and review of literature.
    Sheenu VS; Paul RS; Pushpa M; Ami EM; Rashmi R; Iona ML; Elizabeth M
    Indian J Pathol Microbiol; 2023; 66(2):307-313. PubMed ID: 37077073
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node.
    El Naili R; Nicolas M; Gorena A; Policarpio-Nicolas ML
    Diagn Cytopathol; 2017 May; 45(5):456-462. PubMed ID: 28185421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Review of tubulocystic carcinoma of the kidney with focus on clinical and pathobiological aspects.
    Kuroda N; Matsumoto H; Ohe C; Mikami S; Nagashima Y; Inoue K; Perez-Montiel D; Petersson F; Michal M; Hes O; Yang XJ
    Pol J Pathol; 2013 Dec; 64(4):233-7. PubMed ID: 24375036
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New renal cell carcinomas in the International Society of Urological Pathology Vancouver classification of renal neoplasia.
    Humphrey PA
    J Urol; 2014 Feb; 191(2):473-4. PubMed ID: 24231840
    [No Abstract]   [Full Text] [Related]  

  • 71. [Characterization of different renal cell carcinoma entities].
    Rupp NJ; Moch H
    Urologe A; 2020 Feb; 59(2):135-141. PubMed ID: 31974661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
    Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms.
    Falzarano SM; McKenney JK; Montironi R; Eble JN; Osunkoya AO; Guo J; Zhou S; Xiao H; Dhanasekaran SM; Shukla S; Mehra R; Magi-Galluzzi C
    Am J Surg Pathol; 2016 Jul; 40(7):989-97. PubMed ID: 26975037
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.
    Massari F; Ciccarese C; Hes O; Michal M; Caliò A; Fiorentino M; Giunchi F; D'Amuri A; Sanguedolce F; Sabbatini R; Guida A; Ardizzoni A; Porta C; Iacovelli R; Tortora G; Cima L; Ortega C; Lapini A; Martignoni G; Brunelli M
    Pathol Oncol Res; 2018 Jul; 24(3):447-456. PubMed ID: 28695322
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates.
    Goswami PR; Singh G; Patel T; Dave R
    Cureus; 2024 Apr; 16(4):e58470. PubMed ID: 38765391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.